Miravo Healthcare to present at the Q1 Virtual Investor Summit
MISSISSAUGA, Ontario, March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare™ today announced that Jesse Ledger, President & Chief Financial Officer, will be attending the Q1 Virtual Investor Summit.
| Event | Q1 Investor Summit | ||
| Date | March 23-25th, 2021 | ||
| Presentation | March 24th @ 3:30PM ET | ||
| Location |
About The Investor Summit
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 100 companies and over 300 institutional and retail investors.
To request complimentary investor registration: please visit our website at
Contact:
Brittney Blocker at
About Miravo
Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company’s products target several therapeutic areas, including pain, allergy, neurology and dermatology. The Company’s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Miravo’s head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company’s manufacturing facility is located in Varennes, Québec, Canada. The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S., Canada and E.U. GMP regulations are regularly inspected by Health Canada and the U.S. Food and Drug Administration.
For additional information, please visit
Wire Service Contact
InvestorWire (IW)
Los Angeles, California
212.418.1217 Office
